Unknown

Dataset Information

0

Beta-caryophyllene is a dietary cannabinoid.


ABSTRACT: The psychoactive cannabinoids from Cannabis sativa L. and the arachidonic acid-derived endocannabinoids are nonselective natural ligands for cannabinoid receptor type 1 (CB(1)) and CB(2) receptors. Although the CB(1) receptor is responsible for the psychomodulatory effects, activation of the CB(2) receptor is a potential therapeutic strategy for the treatment of inflammation, pain, atherosclerosis, and osteoporosis. Here, we report that the widespread plant volatile (E)-beta-caryophyllene [(E)-BCP] selectively binds to the CB(2) receptor (K(i) = 155 +/- 4 nM) and that it is a functional CB(2) agonist. Intriguingly, (E)-BCP is a common constituent of the essential oils of numerous spice and food plants and a major component in Cannabis. Molecular docking simulations have identified a putative binding site of (E)-BCP in the CB(2) receptor, showing ligand pi-pi stacking interactions with residues F117 and W258. Upon binding to the CB(2) receptor, (E)-BCP inhibits adenylate cylcase, leads to intracellular calcium transients and weakly activates the mitogen-activated kinases Erk1/2 and p38 in primary human monocytes. (E)-BCP (500 nM) inhibits lipopolysaccharide (LPS)-induced proinflammatory cytokine expression in peripheral blood and attenuates LPS-stimulated Erk1/2 and JNK1/2 phosphorylation in monocytes. Furthermore, peroral (E)-BCP at 5 mg/kg strongly reduces the carrageenan-induced inflammatory response in wild-type mice but not in mice lacking CB(2) receptors, providing evidence that this natural product exerts cannabimimetic effects in vivo. These results identify (E)-BCP as a functional nonpsychoactive CB(2) receptor ligand in foodstuff and as a macrocyclic antiinflammatory cannabinoid in Cannabis.

SUBMITTER: Gertsch J 

PROVIDER: S-EPMC2449371 | biostudies-literature | 2008 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Beta-caryophyllene is a dietary cannabinoid.

Gertsch Jürg J   Leonti Marco M   Raduner Stefan S   Racz Ildiko I   Chen Jian-Zhong JZ   Xie Xiang-Qun XQ   Altmann Karl-Heinz KH   Karsak Meliha M   Zimmer Andreas A  

Proceedings of the National Academy of Sciences of the United States of America 20080623 26


The psychoactive cannabinoids from Cannabis sativa L. and the arachidonic acid-derived endocannabinoids are nonselective natural ligands for cannabinoid receptor type 1 (CB(1)) and CB(2) receptors. Although the CB(1) receptor is responsible for the psychomodulatory effects, activation of the CB(2) receptor is a potential therapeutic strategy for the treatment of inflammation, pain, atherosclerosis, and osteoporosis. Here, we report that the widespread plant volatile (E)-beta-caryophyllene [(E)-B  ...[more]

Similar Datasets

| S-EPMC10604080 | biostudies-literature
| S-EPMC7194099 | biostudies-literature
| S-EPMC6913986 | biostudies-literature
| S-EPMC8157465 | biostudies-literature
| S-EPMC11800524 | biostudies-literature
| S-EPMC4857421 | biostudies-literature
| S-EPMC8508804 | biostudies-literature
| S-EPMC9784863 | biostudies-literature
| S-EPMC6044968 | biostudies-literature
| S-EPMC5532715 | biostudies-literature